» Articles » PMID: 34414240

Effects of Bariatric Surgeries on Fetuin-A, Selenoprotein P, Angiopoietin-Like Protein 6, and Fibroblast Growth Factor 21 Concentration

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2021 Aug 20
PMID 34414240
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a civilization disease representing a global health problem. Excessive body weight significantly reduces the quality of life. It is also associated with the leading causes of death, including type 2 , cardiovascular diseases, and numerous types of cancer. The mainstay of therapy is a dietary treatment. However, in morbidly obese patients, dietary treatment is often insufficient. In these patients, the most effective procedure is bariatric surgery, but it is still difficult to predict its outcome and metabolic changes. Hepatokines are proteins secreted by hepatocytes. Many of them, including fetuin-A, selenoprotein P, angiopoietin-like protein 6, and fibroblast growth factor 21, have been linked to metabolic dysfunctions. In this context, hepatokines may prove helpful. This review investigates the possible changes in hepatokine profiles after selected bariatric surgery protocols. In this regard, gastric bypass is the most studied type of surgery. The overall analysis of published research identified fetuin-A as a potential marker of metabolic alternations in patients after bariatric surgery.

Citing Articles

3-Month Post-Operative Increase in FGF21 is Predictive of One-Year Weight Loss After Bariatric Surgery.

De Luca A, Delaye J, Fauchier G, Bourbao-Tournois C, Champion H, Bourdon G Obes Surg. 2023; 33(8):2468-2474.

PMID: 37391682 DOI: 10.1007/s11695-023-06702-3.


Duodenojejunal Omega Switch Surgery Reduces Oxidative Stress Induced by Cafeteria Diet in Sprague-Dawley Rats.

Poloczek J, Kazura W, Chelmecka E, Michalczyk K, Jochem J, Gumprecht J Nutrients. 2022; 14(19).

PMID: 36235749 PMC: 9573765. DOI: 10.3390/nu14194097.


Serum Fibrinogen-Like Protein 1 Levels in Obese Patients Before and After Laparoscopic Sleeve Gastrectomy: A Six-Month Longitudinal Study.

Dilimulati D, Du L, Huang X, Jayachandran M, Cai M, Zhang Y Diabetes Metab Syndr Obes. 2022; 15:2511-2520.

PMID: 35999870 PMC: 9393035. DOI: 10.2147/DMSO.S374011.


Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.

Perdomo C, Gomez-Ambrosi J, Becerril S, Valenti V, Moncada R, Fernandez-Saez E Int J Mol Sci. 2021; 22(23).

PMID: 34884755 PMC: 8657645. DOI: 10.3390/ijms222312945.

References
1.
Atkinson J, Hill K, Burk R . Centrilobular endothelial cell injury by diquat in the selenium-deficient rat liver. Lab Invest. 2001; 81(2):193-200. DOI: 10.1038/labinvest.3780227. View

2.
Labunskyy V, Lee B, Handy D, Loscalzo J, Hatfield D, Gladyshev V . Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid Redox Signal. 2011; 14(12):2327-36. PMC: 3096499. DOI: 10.1089/ars.2010.3526. View

3.
Potthoff M, Kliewer S, Mangelsdorf D . Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev. 2012; 26(4):312-24. PMC: 3289879. DOI: 10.1101/gad.184788.111. View

4.
Liu Q, Wang S, Wei M, Huang X, Cheng Y, Shao Y . Improved FGF21 Sensitivity and Restored FGF21 Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats After Duodenal-Jejunal Bypass and Sleeve Gastrectomy. Front Endocrinol (Lausanne). 2019; 10:566. PMC: 6728857. DOI: 10.3389/fendo.2019.00566. View

5.
Reinehr T, Karges B, Meissner T, Wiegand S, Fritsch M, Holl R . Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes. J Clin Endocrinol Metab. 2015; 100(8):3004-10. DOI: 10.1210/jc.2015-2192. View